Data / Form D filings / Tangen Biosciences, Inc.
Tangen Biosciences, Inc.: Form D filings
Tangen Biosciences, Inc., a biotechnology company in Branford, CT, filed 5 Form D notices with the SEC between 2015 and 2023. The latest, on June 6, 2023, reports $464,767 sold of a $2.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 COMMERCIAL STREET, Branford, CT, 06405
- Phone
- (203) 433-4045
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1661955
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | New notice | $2,500,000 | $464,767 | $2,035,233 | 9 | May 26, 2023 | sec.gov |
| Jul 1, 2020 | New notice | $20,000,000 | $11,239,731 | $8,760,269 | 39 | Jun 19, 2020 | sec.gov |
| Mar 22, 2019 | New notice | $11,069,342 | $6,689,846 | $4,379,496 | 29 | Mar 14, 2019 | sec.gov |
| Nov 2, 2016 | New notice | $8,000,000 | $0 | $8,000,000 | 0 | Yet to occur | sec.gov |
| Dec 28, 2015 | New notice | $3,030,403 | $2,030,403 | $1,000,000 | 8 | Dec 14, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan V. Levin | Director | |
| Richard C. Birkmeyer, PhD | Executive Officer, Director | |
| Vance V. Kershner | Director | |
| Daniel V. Wagner | Director | |
| Christopher V. McLeod | Director | |
| John V. Davidson | Executive Officer, Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Jun 5, 2023 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tangen Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.